Terms: = Pancreatic cancer AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987 AND Prognosis
26 results:
1. PELI1: key players in the oncogenic characteristics of pancreatic cancer.
Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
[TBL] [Abstract] [Full Text] [Related]
2. Actinomycin D synergizes with Doxorubicin in triple-negative breast cancer by inducing P53-dependent cell apoptosis.
Yang H; Li S; Li W; Yang Y; Zhang Y; Zhang S; Hao Y; Cao W; Xu F; Wang H; Du G; Wang J
Carcinogenesis; 2024 Apr; 45(4):262-273. PubMed ID: 37997385
[TBL] [Abstract] [Full Text] [Related]
3. Molecular and Functional Heterogeneity of Primary pancreatic Neuroendocrine Tumors and Metastases.
Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
[TBL] [Abstract] [Full Text] [Related]
4. miR-3,178 contributes to the therapeutic action of baicalein against hepatocellular carcinoma cells via modulating HDAC10.
Qi J; Li J; Bie B; Shi M; Zhu M; Tian J; Zhu K; Sun J; Mu Y; Li Z; Guo Y
Phytother Res; 2023 Jan; 37(1):295-309. PubMed ID: 36070933
[TBL] [Abstract] [Full Text] [Related]
5. Long noncoding RNA Linc01612 represses hepatocellular carcinoma progression by regulating miR-494/ATF3/p53 axis and promoting ubiquitination of YBX1.
Liu P; Zhong Q; Song Y; Guo D; Ma D; Chen B; Lan J; Liu Q
Int J Biol Sci; 2022; 18(7):2932-2948. PubMed ID: 35541917
[TBL] [Abstract] [Full Text] [Related]
6. Integrated multi-omics profiling of high-grade estrogen receptor-positive, HER2-negative breast cancer.
Wang K; Li L; Franch-Expósito S; Le X; Tang J; Li Q; Wu Q; Bassaganyas L; Camps J; Zhang X; Li H; Foukakis T; Xiang T; Wu J; Ren G
Mol Oncol; 2022 Jun; 16(12):2413-2431. PubMed ID: 34146382
[TBL] [Abstract] [Full Text] [Related]
7. Holliday junction recognition protein promotes pancreatic cancer growth and metastasis via modulation of the mdm2/p53 signaling.
Wang CJ; Li X; Shi P; Ding HY; Liu YP; Li T; Lin PP; Wang YS; Zhang GQ; Cao Y
Cell Death Dis; 2020 May; 11(5):386. PubMed ID: 32439850
[TBL] [Abstract] [Full Text] [Related]
8. Ras-ERK1/2 signalling promotes the development of osteosarcoma through regulation of H4K12ac through HAT1.
Zhang J; Liu M; Liu W; Wang W
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1207-1215. PubMed ID: 30942624
[TBL] [Abstract] [Full Text] [Related]
9. Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer.
Zhang H; Zhang X; Li X; Meng WB; Bai ZT; Rui SZ; Wang ZF; Zhou WC; Jin XD
J Cell Physiol; 2018 Jan; 234(1):619-631. PubMed ID: 30069972
[TBL] [Abstract] [Full Text] [Related]
10. Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals.
Abrams SL; Lertpiriyapong K; Yang LV; Martelli AM; Cocco L; Ratti S; Falasca M; Murata RM; Rosalen PL; Lombardi P; Libra M; Candido S; Montalto G; Cervello M; Steelman LS; McCubrey JA
Adv Biol Regul; 2018 Aug; 69():16-34. PubMed ID: 29980405
[TBL] [Abstract] [Full Text] [Related]
11. MYL6B, a myosin light chain, promotes mdm2-mediated p53 degradation and drives HCC development.
Xie X; Wang X; Liao W; Fei R; Wu N; Cong X; Chen Q; Wei L; Wang Y; Chen H
J Exp Clin Cancer Res; 2018 Feb; 37(1):28. PubMed ID: 29439719
[TBL] [Abstract] [Full Text] [Related]
12. YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/mdm2/P53/P21 signaling pathway.
Liu D; Zhang J; Wu Y; Shi G; Yuan H; Lu Z; Zhu Q; Wu P; Lu C; Guo F; Chen J; Jiang K; Miao Y
Int J Cancer; 2018 Apr; 142(7):1392-1404. PubMed ID: 29168185
[TBL] [Abstract] [Full Text] [Related]
13. Cooperation of Musashi-2, Numb, mdm2, and P53 in drug resistance and malignant biology of pancreatic cancer.
Sheng W; Dong M; Chen C; Wang Z; Li Y; Wang K; Li Y; Zhou J
FASEB J; 2017 Jun; 31(6):2429-2438. PubMed ID: 28223335
[TBL] [Abstract] [Full Text] [Related]
14. ZEB1-induced tumourigenesis requires senescence inhibition via activation of DKK1/mutant p53/mdm2/CtBP and repression of macroH2A1.
de Barrios O; Győrffy B; Fernández-Aceñero MJ; Sánchez-Tilló E; Sánchez-Moral L; Siles L; Esteve-Arenys A; Roué G; Casal JI; Darling DS; Castells A; Postigo A
Gut; 2017 Apr; 66(4):666-682. PubMed ID: 27965283
[TBL] [Abstract] [Full Text] [Related]
15. Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein.
Dong C; Zhao B; Long F; Liu Y; Liu Z; Li S; Yang X; Sun D; Wang H; Liu Q; Liang R; Li Y; Gao Z; Shao S; Miao QR; Wang L
Oncotarget; 2016 Feb; 7(8):8850-65. PubMed ID: 26840457
[TBL] [Abstract] [Full Text] [Related]
16. Parp-1 genetic ablation in Ela-myc mice unveils novel roles for Parp-1 in pancreatic cancer.
Martínez-Bosch N; Iglesias M; Munné-Collado J; Martínez-Cáceres C; Moreno M; Guerra C; Yélamos J; Navarro P
J Pathol; 2014 Oct; 234(2):214-27. PubMed ID: 24889936
[TBL] [Abstract] [Full Text] [Related]
17. [Correlation between Gli1 expression and clinicopathological significance in human pancreatic cancer].
Sheng WW; Dong M; Zhou JP; Liu QF; Li X; Dong Q
Zhonghua Wai Ke Za Zhi; 2013 Oct; 51(10):916-21. PubMed ID: 24433772
[TBL] [Abstract] [Full Text] [Related]
18. The clinicopathological significance and relationship of Gli1, mdm2 and p53 expression in resectable pancreatic cancer.
Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
Histopathology; 2014 Mar; 64(4):523-35. PubMed ID: 24289472
[TBL] [Abstract] [Full Text] [Related]
19. Elevated transcript levels from the mdm2 P1 promoter and low p53 transcript levels are associated with poor prognosis in human pancreatic ductal adenocarcinoma.
Grochola LF; Taubert H; Greither T; Bhanot U; Udelnow A; Würl P
Pancreas; 2011 Mar; 40(2):265-70. PubMed ID: 21404460
[TBL] [Abstract] [Full Text] [Related]
20. Identification of liver metastasis-related genes in a novel human pancreatic carcinoma cell model by microarray analysis.
Shi WD; Meng ZQ; Chen Z; Lin JH; Zhou ZH; Liu LM
Cancer Lett; 2009 Sep; 283(1):84-91. PubMed ID: 19375852
[TBL] [Abstract] [Full Text] [Related]
[Next]
